Susan Romanus
Net worth: 181 466 $ as of 2024-06-29
Profile
Susan Romanus worked as a Senior Director & Compliance Officer at Merck Vaccine Division.
She then worked as Vice President, Chief Ethics & Compliance Officer at Daiichi Sankyo Co., Ltd.
Later, she worked as Chief Compliance & Quality Officer at ADC Therapeutics SA. Finally, she worked as Vice President-Compliance at Taiho Oncology, Inc. Ms. Romanus completed her undergraduate degree from the University of California San Diego and her MBA from the University of San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0.06% | 2023-01-31 | 57,426 ( 0.06% ) | 181 466 $ | 2024-06-29 |
Former positions of Susan Romanus
| Companies | Position | End |
|---|---|---|
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Compliance Officer | 2017-12-31 |
| DAIICHI SANKYO CO., LTD. | Compliance Officer | 2011-12-31 |
| Merck Vaccine Division | Compliance Officer | - |
| ADC THERAPEUTICS SA | Compliance Officer | - |
Training of Susan Romanus
| University of California San Diego | Undergraduate Degree |
| University of San Diego | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| Private companies | 2 |
|---|---|
| Merck Vaccine Division | |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Susan Romanus
